The hottest Lab Automation Substack posts right now

And their main takeaways
Category
Top Technology Topics

Solving the Electroporation Bottleneck

Asimov Press • 335 implied HN points • 15 Jan 26
🔬 Science Lab Automation
  1. Electroporation has a huge space of possible settings, so getting DNA into non-model microbes is often slow, hit-or-miss, and leaves researchers unsure why experiments fail.
  2. A robotic electroporator that tests many buffers, voltages, waveforms, and plasmid origins—and uses a Bayesian optimizer to choose conditions—can rapidly find working protocols and massively improve transformation efficiency.
  3. Scaling cultivation and transformation for diverse microbes will open up study and engineering of vast, untapped biological diversity, leading to new enzymes, tools, and biotech applications beyond standard lab organisms.

Roche SBX Interest High, Workflow Questions

ASeq Newsletter • 21 implied HN points • 03 Mar 26
đź•ą Technology Lab Automation
  1. Interest in Roche’s Axelios sequencer is high and early reactions to AGBT pricing look positive.
  2. If those early responses hold, about 58% of NovaSeq X sales could shift to Axelios, roughly 150 units based on 2025 Illumina numbers.
  3. That level of market shift is probably unrealistic, so real-world impact is uncertain and likely smaller.

RapidHIT ID

ASeq Newsletter • 14 implied HN points • 05 Dec 25
đź•ą Technology Lab Automation
  1. RapidHIT ID is a point-of-use forensic DNA profiling system that generates STR profiles for quick, on-site analysis.
  2. Forensic STR profiling typically looks at about 20 loci, and RapidHIT ID works as a sample-to-answer PCR device with capillary readout to produce those profiles.
  3. STRs remain the practical standard largely because of huge existing STR databases, lower costs, and institutional conservatism, and the technology has been simplified from complex lab rigs into much simpler cartridges.

DNAe Early Access

ASeq Newsletter • 7 implied HN points • 19 Dec 25
đź•ą Technology Lab Automation
  1. DNAe has launched an early-access program for a sample-to-answer platform they describe as NGS-capable, but the public early version likely uses targeted primer-extension detection rather than full sequencing.
  2. The system uses vacutainer-style cartridges with magnetic‑bead extraction and an ion-based yes/no readout, making it behave more like a high‑plex PCR/FilmArray-style device for rapid sepsis and AMR testing.
  3. The company has been developing this technology for over two decades with alpha instruments and a hospital trial since 2023, and it operates with complex funding (grants and corporate backing) alongside large intercompany debt implying total spend/raise well over $500M.

QuantumDx

ASeq Newsletter • 0 implied HN points • 10 Feb 26
đź•ą Technology Lab Automation
  1. QuantumDx has shifted from researching FET nanowire DNA sequencing to developing sample-to-answer qPCR platforms.
  2. This represents a big technological pivot toward a more conservative, near-term, market-ready diagnostics strategy instead of experimental sequencing hardware.
  3. The latest update about the company is published as paid, subscriber-only content.
Get a weekly roundup of the best Substack posts, by hacker news affinity: